Detection of novel and potentially actionable anaplastic lymphoma kinase (ALK) rearrangement in colorectal adenocarcinoma by immunohistochemistry screening-Reference-Cited by-同舟云学术

Detection of novel and potentially actionable anaplastic lymphoma kinase (ALK) rearrangement in colorectal adenocarcinoma by immunohistochemistry screening

Published:2015-07-01 Issue:27 Volume:6 Page:24320-24332
ISSN:1949-2553
Container-title:Oncotarget
language:en
Short-container-title:Oncotarget

Author:

Lee Jeeyun¹,Kim Hee Cheol²,Hong Jung Yong³,Wang Kai⁴,Kim Sun Young¹,Jang Jiryeon¹,Kim Seung Tae¹,Park Joon Oh¹,Lim Ho Yeong¹,Kang Won Ki¹,Park Young Suk¹,Lee Jiyun¹,Lee Woo Yong²,Park Yoon Ah²,Huh Jung Wook²,Yun Seong Hyeon²,Do In-Gu⁵,Kim Seok Hyung⁵,Balasubramanian Sohail⁴,Stephens Philip J.⁴,Ross Jeffrey S.⁴⁶,Li Gang Gary⁷,Hornby Zachary⁷,Ali Siraj M.⁴,Miller Vincent A.⁴,Kim Kyoung-Mee⁵⁸,Ou Sai-Hong Ignatius⁹

Affiliation:

1. Department of Medicine, Division of Hematology-Oncology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea

2. Department of Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea

3. Department of Internal Medicine, Chung-Ang University College of Medicine, Dongjak-Gu, Seoul, Republic of Korea

4. Foundation Medicine Inc, Cambridge, Massachusetts, USA

5. Department of Pathology and Translational Genomics, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea

6. Department of Pathology and Laboratory Medicine, Albany Medical College, Albany, New York, USA

7. Ignyta Inc, San Diego, California, USA

8. Innovative Cancer Medicine Institute, Samsung Medical Center, Seoul, Korea

9. Chao Family Comprehensive Cancer Center, University of California Irvine School of Medicine, Orange, California, USA

Publisher

Impact Journals, LLC

Subject

Oncology

Cited by 33 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Reduced expression of SOX11 in colorectal adenocarcinoma is associated with mucinous and signet ring cell types, poor survival, and lower ALK expression;Pathology - Research and Practice;2024-08

2. Anaplastic Lymphoma Kinase (ALK) Inhibitors Show Activity in Colorectal Cancer With ALK Rearrangements: Case Series and Literature Review;The Oncologist;2024-02-21

3. Exploring the binding affinity of rutin, catechin, and epicatechin to ALK and caspase-3: implications for colorectal cancer treatment;Pharmacy Reports;2023-12-31

5. Gene fusions and oncogenic mutations in MLH1 deficient and BRAFV600E wild-type colorectal cancers;Virchows Archiv;2022-03-03